Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02640833
Brief Title: A Study of Duvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K Inhibitor

First Submitted : December 23, 2015
First Submitted that Met QC Criteria : December 23, 2015
First Posted : December 29, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : July 22, 2016
Last Update Posted : July 26, 2016 (Estimate)